Novo Nordisk (NVO)
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine
Google Lens on iPhone Just Got Smarter: AI Search, Screen Gestures, and YouTube
Suuran Digit Out Now On Nintendo Switch
The Latest on Squid Game: Season 3, Casting, Fortnite Crossover & More
Pokémon Legends: Z-A – Release Date, Gameplay, Mega Evolutions
The Latest on ChatGPT & MCP: A Major Leap in AI Integration and Data Connectivity
No Sony Walkman Refresh in Sight
AMD Leaks Upcoming Ryzen 5 9600X3D 3D V-Cache Gaming Chip
The White Lotus Season 4: Everything We Know So Far
Netflix’s Mindhunter Might Return — But As A Movie Trilogy, Not Season 3